Investigation Overview
An investigation on behalf of investors, who currently hold shares of Ignyta Inc (NASDAQ:RXDX), was announced concerning whether the takeover of Ignyta Inc by Roche for $27.00 per share is unfair to NASDAQ:RXDX stockholders. The investigation by a law firm concerns whether certain officers and directors of Ignyta Inc breached their fiduciary duties owed to NASDAQ:RXDX investors in co...
You must register (for free) or login to view the entire investigation.